Roche has raised a warning flag on Hemlibra, noting the first case where a hemophilia patient developed anti-drug antibodies that made the drug ineffective.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,